Table 2. In Vitro ADME and PK Parameters for Lead MEK Inhibitors.
rat PK parametersa |
|||||||
---|---|---|---|---|---|---|---|
compd | MDCKb | RLMc | HLMc | Cl (mL/h/kg) | oral t1/2 (h) | F % | AUC/dosed |
7 | 399 | 80.1 | 30.8 | 8324 | 1.5 | 19 | 0.05 |
8 | 43 | 16.2 | 755 | 9.1 | 78 | 1.57 | |
12 | 207 | 31.5 | 46.3 | 2101 | 5.4 | 101 | 0.85 |
13 | 210 | 40.5 | 35.8 | 5958 | 4.9 | 86 | 0.25 |
18 | 99 | –4.5 | 2.6 | 800 | 11.4 | 58 | 1.03 |
1 | 105 | 22.4 | 13.8 | 3565 | 6.1 | 77 | 0.35 |
Compounds were prepared as amorphous solids and dosed at 5 mg/kg in female CD rats.
Cell permeability Papp nm/s.
% Conversion in the presence of rat and human liver microsomes at 0.5 mg/mL microsomal concentration supplemented with NADPH and at 15 μM substrate concentration at 37 °C for 30 min.
Oral AUC (0–t) normalized to dose (μM h/mg/kg).